Hylomorph

📍 Zurich, Switzerland🗓 Founded 2014👥 12 employees💰 Last funded Aug 2018
Medical Equipment Manufacturing🌐 hylomorph-medical.com
Website LinkedIn
Hylomorph is an innovative Medtech company engineering biomaterials to optimize the interface between implants and their surrounding biological tissues. We aim at preventing post operative complications in implantable medical devices. Our mission is to improve quality of life in patients and the quality of care by health professionals. ​ Our proprietary CellSense technology was developed in the cutting-edge laboratories of the Swiss Federal Institute of Technology (ETH Zurich). Hylomorph's first product, Hylomate, has demonstrated outstanding performance in limiting the foreign body reaction and fibrotic buildup in pre-clinical settings and is currently undergoing first-in-man clinical trials in Germany.
2
Total investors
0
Early stage
2
Mid stage
0
Late stage
2014
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Switzerland
1
Frequently asked questions
Who invested in Hylomorph?
Hylomorph has 2 investors on record on gritt.io, 2 mid-stage.
When did Hylomorph last raise funding?
The most recent investment in Hylomorph recorded on gritt.io was in August 2018.
When was Hylomorph founded?
Hylomorph was founded in 2014.
What industry is Hylomorph in?
Hylomorph operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Hylomorph based?
Hylomorph is headquartered in Zurich, Switzerland.